Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-025170)

Filing Details

Accession Number:: 0001209191-17-025170
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-04 17:37:58
Reporting Period:: 2017-03-31

Filing Date:: 2017-04-04
Accepted Time:: 2017-04-04 17:37:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1016169	Antares Pharma Inc.	ATRS	Surgical & Medical Instruments & Apparatus (3841)	411350192

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1275012	J Thomas Garrity	C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-03-31	30,000	$1.65	190,213	No	4	M	Direct
Common Stock	Disposition	2017-03-31	30,000	$2.91	160,213	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-03-31	30,000	$0.00	30,000	$1.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-05-10	No	4	M	Direct

Footnotes

The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The exercised stock option reported on this Form 4 was due to expire on May 10, 2017.
The options vested and became exercisable in four equal quarterly installments following the grant date of May 10, 2007.